Cancer immunotherapy, also called biologic therapy, which can predominantly be classed as a form of targeted therapy, It is designed to stimulate the body's immune system to attack tumours.
This report contains market size and forecasts of Cancer Immunotherapies in global, including the following market information:
Global Cancer Immunotherapies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Immunotherapies Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cancer Immunotherapies companies in 2021 (%)
The global Cancer Immunotherapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies (MABs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Immunotherapies include Amgen, AstraZeneca, Roche, Bristol-Myers Squibb, Bayer, Merck, ARMO BioSciences (Eli Lilly), Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Immunotherapies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Immunotherapies Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Immunotherapies Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies (MABs)
Cancer Vaccines
Immunomodulators
Adoptive Cell transfer
Checkpoint Inhibitors
Global Cancer Immunotherapies Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Immunotherapies Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Leukemia
Lymphoma
Melanoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Global Cancer Immunotherapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Immunotherapies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Immunotherapies revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Immunotherapies revenues share in global market, 2021 (%)
Key companies Cancer Immunotherapies sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cancer Immunotherapies sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
AstraZeneca
Roche
Bristol-Myers Squibb
Bayer
Merck
ARMO BioSciences (Eli Lilly)
Novartis
Pfizer
Johnson & Johnson
AbbVie
Gilead Sciences